Significant clinical morbidity for non-musculoskeletal disorders by case and control groups
Morbidity (Read code) | OA cases No (%) | Non-OA controls No (%) | OR* (99 % CI) |
---|---|---|---|
*Adjusted for age, sex, and social class; non-OA group is reference group, all statistically significant at 1% level; †results (not shown) which were significant at 1% level when adjusted for age, sex, social class, and categories of morbidity counts as defined by number of specific disease groups each subject had consulted for in the study year; non-OA group is the reference group. | |||
Obesity and other disorders (C38) | 317 (2.8) | 148 (1.3) | 2.25 (1.73 to 2.92)† |
Gastritis and duodenitis (J15) | 214 (1.9) | 113 (1.0) | 1.98 (1.46 to 2.68)† |
Phlebitis and thrombophlebitis (G80) | 161 (1.4) | 93 (0.8) | 1.80 (1.28 to 2.52)† |
Diaphragmatic (hiatus) hernia (J34) | 167 (1.5) | 95 (0.8) | 1.80 (1.29 to 2.51)† |
Ischaemic heart disease (G3) | 97 (0.9) | 58 (0.5) | 1.73 (1.13 to 2.66)† |
Cellulitis and abscess of finger or toe (M02) | 124 (1.1) | 76 (0.6) | 1.67 (1.14 to 2.43)† |
Diverticula of intestine (J51) | 179 (1.6) | 114 (1.0) | 1.63 (1.20 to 2.23)† |
Other procedure complication (SP2) | 100 (0.9) | 66 (0.6) | 1.63 (1.08 to 2.45) |
Lachrymal system disorders (F4F) | 174 (1.5) | 112 (1.0) | 1.61 (1.18 to 2.21)† |
Disorders of stomach function (J16) | 631 (5.5) | 407 (3.5) | 1.61 (1.36 to 1.90)† |
Gout (C34) | 196 (1.7) | 134 (1.1) | 1.53 (1.14 to 2.05)† |
Acute respiratory infections (H0.) | 190 (1.7) | 126 (1.1) | 1.53 (1.13 to 2.06)† |
Chronic pharyngitis and nasopharyngitis (H12) | 224 (2.0) | 153 (1.3) | 1.51 (1.15 to 1.99)† |
Chronic skin ulcer (M27) | 118 (1.0) | 81 (0.7) | 1.49 (1.02 to 2.17) |
Urinary system symptoms (R08) | 234 (2.1) | 163 (1.4) | 1.48 (1.13 to 1.93) |
Erythematosquamous dermatosis (M10) | 139 (1.2) | 97 (0.8) | 1.47 (1.04 to 2.08) |
Depressive disorder (E2B) | 314 (2.8) | 223 (1.9) | 1.45 (1.15 to 1.82) |
Varicose veins of the legs (G83) | 423 (3.7) | 307 (2.6) | 1.42 (1.17 to 1.73)† |
Dermatitis or other eczema (M12) | 327 (2.9) | 239 (2.0) | 1.42 (1.14 to 1.78)† |
Iron deficiency anaemia (D00) | 186 (1.6) | 134 (1.1) | 1.41 (1.05 to 1.89) |
Fall on same level (TC5) | 368 (3.2) | 267 (2.3) | 1.40 (1.13 to 1.73) |
Functional gastrointestinal disorders (J52) | 600 (5.3) | 448 (3.8) | 1.38 (1.17 to 1.63) |
Symptoms affecting skin and other tissues (R02) | 524 (4.6) | 397 (3.4) | 1.37 (1.15 to 1.64)† |
Angina pectoris (G33) | 654 (5.7) | 499 (4.2) | 1.36 (1.16 to 1.59)† |
Digestive system symptoms (R07) | 243 (2.1) | 183 (1.6) | 1.35 (1.04 to 1.74) |
Adverse effects (SN5) | 596 (5.2) | 459 (3.9) | 1.35 (1.14 to 1.59) |
Erythematous conditions (M15) | 213 (1.9) | 164 (1.4) | 1.33 (1.01 to 1.74) |
Peripheral vascular disease (G73) | 216 (1.9) | 168 (1.4) | 1.32 (1.01 to 1.72) |
Diseases of oesophagus (J10) | 396 (3.5) | 309 (2.6) | 1.32 (1.08 to 1.61) |
Injury – accidental, by other means (TN8) | 1516 (13.3) | 1228 (10.4) | 1.32 (1.18 to1.46) |
Other urethral and urinary tract disorders (K19) | 716 (6.3) | 563 (4.8) | 1.31 (1.13 to 1.52) |
Other cellulitis and abscess (M03) | 297 (2.6) | 233 (2.0) | 1.31 (1.04 to 1.64) |
Candidiasis (AB2) | 259 (2.3) | 206 (1.7) | 1.30 (1.02 to 1.66) |
Heart failure (G58) | 542 (4.8) | 432 (3.7) | 1.28 (1.07 to 1.52) |
Head and neck symptoms (R04) | 308 (2.7) | 246 (2.1) | 1.28 (1.02 to 1.60) |
Disorders of conjunctiva (F4C) | 667 (5.9) | 559 (4.7) | 1.24 (1.06 to 1.44) |
General symptoms (R00) | 858 (7.5) | 713 (6.1) | 1.24 (1.09 to 1.42) |
Other abdominal and pelvic symptoms (R09) | 440 (3.9) | 369 (3.1) | 1.23 (1.02 to 1.48) |
Ill-defined intestinal tract infections (A08) | 391 (3.4) | 329 (2.8) | 1.22 (1.00 to 1.48) |
Respiratory system and chest symptoms (R06) | 710 (6.2) | 604 (5.1) | 1.22 (1.05 to 1.41) |
Other acute upper respiratory infections (H05) | 574 (5.0) | 487 (4.1) | 1.21 (1.03 to 1.43) |
Neurotic disorders (E20) | 810 (7.1) | 706 (6.0) | 1.18 (1.03 to 1.36) |
Acute bronchitis and bronchiolitis (H06) | 1705 (15.0) | 1565 (13.3) | 1.13 (1.02 to 1.24) |
Senile or pre-senile organic psychosis (E00) | 62 (0.5) | 94 (0.8) | 0.65 (0.43 to 1.00)† |